| Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic Cough (NCT05110144) | Mayo Clinic | 2021-11-01 |
| COllaboration REsearch on Chronic Cough (COREC): a French Multicenter Database (NCT04882943) | University Hospital, Toulouse | 2021-06-22 |
| Indomethacin for Refractory Chronic Cough (NCT03662269) | The First Affiliated Hospital of Guangzhou Medical University | 2018-10-22 |
| Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough (NCT03282591) | Vyne Therapeutics Inc. | 2017-10-03 |
| An 8-Week Refractory Chronic Cough Study (MK-7264-021) (NCT02612623) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-12-17 |
| A 12-Week Study in Participants With Refractory Chronic Cough (MK-7264-012) (NCT02612610) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-12-15 |
| Effect of Gefapixant (MK-7264/AF-219) on Cough Reflex Sensitivity in Healthy and Chronic Cough Participants (MK-7264-014) (NCT02476890) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-10-28 |
| Effect of Gefapixant (AF-219/MK-7264) on Cough Reflex Sensitivity (MK-7264-015) (NCT02397460) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-04-29 |
| A Dose Escalation Study of Gefapixant (AF-219/MK-7264) in Refractory Chronic Cough (MK-7264-010) (NCT02349425) | Afferent Pharmaceuticals, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-03-09 |
| Treatment of Refractory Chronic Cough With PA101 (NCT02412020) | Patara Pharma | 2015-02-01 |